Alere Inc (ALR)

ALR on New York Consolidated

41.14USD
15 Sep 2014
Price Change (% chg)

$4.53 (+12.37%)
Prev Close
$36.61
Open
$42.22
Day's High
$43.00
Day's Low
$40.87
Volume
4,623,959
Avg. Vol
--
52-wk High
--
52-wk Low
--

ALR

Chart for ALR

About

Alere Inc. is a provider of point-of-care diagnostics and services. The Company's products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company's portfolio also includes a range of health information solutions that access to critical... (more)

Overall

Beta: 1.95
Market Cap (Mil.): $3,041.80
Shares Outstanding (Mil.): 83.09
Dividend: --
Yield (%): --

Financials

  ALR Industry Sector
P/E (TTM): -- 42.26 33.52
EPS (TTM): -1.22 -- --
ROI: -1.50 6.85 17.33
ROE: -6.97 10.97 18.19
Search Stocks

Deals of the day- Mergers and acquisitions

(Adds SABMiller, Orange, BNP Paribas, AbbVie, America Movil, Microsoft, Club Mediterranee, JSW Steel, Alere, GFI Group, AngloGold Ashanti, Qatar National Bank and Telekom)

15 Sep 2014

Alere's former CEO offers to take company private

- Alere Inc's former Chief Executive Ron Zwanziger said he intends to take the diagnostic device and service provider private in a deal that values the company at $3.82 billion.

15 Sep 2014

UPDATE 1-Alere's former CEO offers to take company private

Sept 15 - Alere Inc's former Chief Executive Ron Zwanziger said he intends to take the diagnostic device and service provider private in a deal that values the company at $3.82 billion.

15 Sep 2014

Alere's former CEO offers to take company private

Sept 15 - Alere Inc's former Chief Executive Ron Zwanziger said he intends to take the diagnostic company private in a deal that values it at $3.82 billion.

15 Sep 2014

CORRECTED-U.S. CDC recommends combo HIV test for faster detection of virus

(Corrects in paragraph 3 to show company making recommended test is Bio-Rad Laboratories, not Alere Inc)

27 Jun 2014

Alere starts urgent recall of some blood clot test strips

- Alere Inc said it initiated a voluntary recall of certain blood clot test strips in the United States following reports of nine serious adverse events that included bleeding related to the death of three patients.

06 May 2014

Alere starts urgent recall of some blood clot test strips

May 6 - Alere Inc said it initiated a voluntary recall of certain blood clot test strips in the United States following reports of nine serious adverse events that included bleeding related to the death of three patients.

06 May 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks